Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
Eugene Tulchinsky, Oleg N. Demidov, Marina Kriajevska, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1871, Iss. 1, pp. 29-39
Closed Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 511
Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
Yuanyuan Jiang, Hanxiang Zhan
Cancer Letters (2019) Vol. 468, pp. 72-81
Closed Access | Times Cited: 272
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 148
AXL in cancer: a modulator of drug resistance and therapeutic target
Yaoxiang Tang, Hongjing Zang, Qiuyuan Wen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 47
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Lingpu Zhang, Jia‐Zhen Yang, Jia Huang, et al.
Chem (2024) Vol. 10, Iss. 5, pp. 1337-1356
Closed Access | Times Cited: 22
Acquired resistance to targeted therapies in NSCLC: Updates and evolving insights
Catherine B. Meador, Aaron N. Hata
Pharmacology & Therapeutics (2020) Vol. 210, pp. 107522-107522
Open Access | Times Cited: 86
Role of ACTN4 in Tumorigenesis, Metastasis, and EMT
Dmitri Tentler, Ekaterina Lomert, Ksenia Novitskaya, et al.
Cells (2019) Vol. 8, Iss. 11, pp. 1427-1427
Open Access | Times Cited: 79
FGL1 regulates acquired resistance to Gefitinib by inhibiting apoptosis in non-small cell lung cancer
Cuilan Sun, Weiwei Gao, Jiatao Liu, et al.
Respiratory Research (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 79
EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression
Meiqin Yang, Haoran Hu, Sufang Wu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 62
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment
Mathieu Seyfrid, William Maich, Muhammad Vaseem Shaikh, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003289-e003289
Open Access | Times Cited: 53
Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer
Zhongning He, Chunyu Zhang, Yuwei Zhao, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 15
The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door
Francesco Talotta, Laura Casalino, Pasquale Verde
Oncogene (2020) Vol. 39, Iss. 23, pp. 4491-4506
Closed Access | Times Cited: 57
Layer-by-Layer assembled nano-drug delivery systems for cancer treatment
Xinyi Zhang, Tianying Liang, Qingming Ma
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 655-669
Open Access | Times Cited: 53
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade
Kartik Sehgal, Andrew Portell, Elena Ivanova, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 2
Open Access | Times Cited: 52
MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
Shengjie Tang, Shuangjiang Li, Tao Liu, et al.
Cancer Letters (2021) Vol. 502, pp. 71-83
Closed Access | Times Cited: 46
Meclofenamic Acid Restores Gefinitib Sensitivity by Downregulating Breast Cancer Resistance Protein and Multidrug Resistance Protein 7 via FTO/m6A-Demethylation/c-Myc in Non-Small Cell Lung Cancer
Hui Chen, Bin Jia, Qiang Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 37
Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer
Erbao Chen, Jing Yi, Jing Jiang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 30
Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data
Julian A. Marin‐Acevedo, Bruna Pellini, ErinMarie O. Kimbrough, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 629-629
Open Access | Times Cited: 23
Epithelial–mesenchymal transition to Mitigate Age-Related Progression in Lung Cancer
Riya Thapa, Saurabh Gupta, Gaurav Gupta, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102576-102576
Closed Access | Times Cited: 8
Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib
Chengzhong Lin, Zhenhu Ren, Xi Yang, et al.
Cancer Letters (2019) Vol. 472, pp. 81-96
Closed Access | Times Cited: 53
Contribution of Epithelial Plasticity to Therapy Resistance
Patricia G. Santamarı́a, Gema Moreno‐Bueno, Amparo Cano
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 676-676
Open Access | Times Cited: 50
Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential
Dongsong Nie, Jiewen Fu, Hanchun Chen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 861-861
Open Access | Times Cited: 45
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Almira Auyez, A. Emre Sayan, Marina Kriajevska, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4864-4864
Open Access | Times Cited: 38
Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression
Yinying Dong, Xiangyin Sun, Kong Zhang, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 12967-12979
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top